Featured Research

from universities, journals, and other organizations

Hormone Replacement Therapy Trial Stopped Early After 'Unacceptable Risks' For Women With Previous Breast Cancer

Date:
February 5, 2004
Source:
Harbor-UCLA Research And Education Institute (REI)
Summary:
A Swedish study established to assess the effect of hormone replacement therapy (HRT) for women with a history of breast cancer has been stopped early after preliminary results show 'unacceptably high' risks of breast cancer recurrence for HRT users. The results are published online by THE LANCET (3 February 2004) and will appear in the February 7 print edition.

A Swedish study established to assess the effect of hormone replacement therapy (HRT) for women with a history of breast cancer has been stopped early after preliminary results show 'unacceptably high' risks of breast cancer recurrence for HRT users. The results are published online by THE LANCET (3 February 2004) and will appear in the February 7 print edition.

Related Articles


The increasing survival of women with breast cancer has made the management of menopause (either natural or early-onset due to hormone therapy or chemotherapy) an important clinical issue. The HABITS trial (Hormonal replacement therapy after breast cancer diagnosis--is it safe?) was one of several trials established in the 1990s to assess the possible risk of recurrent breast cancer for women using HRT. Originally planned to include at least 1300 women followed up for five years, the trial was stopped on December 17, 2003, after an average follow-up of just over two years. The steering committee for the trial were concerned that early results from the study showed an unacceptably high risk of recurrent breast cancer for those women randomized to receive HRT; of 345 women (all of whom had had previous breast cancer and were randomized to HRT or no HRT) with at least one follow-up assessment, 26 in the study arm allocated HRT reported a recurrence (or a new case) of breast cancer, compared with seven women who received therapy other than HRT for menopausal symptoms.

In an accompanying Commentary, Rowan T Chlebowski (Harbor-UCLA Research and Education Institute, USA) and Nananda Col (Brigham and Women's Health Hospital, Boston, USA) conclude: "…considering all available evidence about the effect of hormone therapy on breast cancer and chronic disease, the HABITS investigators' conclusion that even short-term use of hormone therapy poses an unacceptably high risk of breast cancer can now reasonably guide clinical practice for women with breast cancer…Alternative safe and effective strategies for the difficult problem of menopausal symptoms in these women now need to be developed".


Story Source:

The above story is based on materials provided by Harbor-UCLA Research And Education Institute (REI). Note: Materials may be edited for content and length.


Cite This Page:

Harbor-UCLA Research And Education Institute (REI). "Hormone Replacement Therapy Trial Stopped Early After 'Unacceptable Risks' For Women With Previous Breast Cancer." ScienceDaily. ScienceDaily, 5 February 2004. <www.sciencedaily.com/releases/2004/02/040203234441.htm>.
Harbor-UCLA Research And Education Institute (REI). (2004, February 5). Hormone Replacement Therapy Trial Stopped Early After 'Unacceptable Risks' For Women With Previous Breast Cancer. ScienceDaily. Retrieved March 3, 2015 from www.sciencedaily.com/releases/2004/02/040203234441.htm
Harbor-UCLA Research And Education Institute (REI). "Hormone Replacement Therapy Trial Stopped Early After 'Unacceptable Risks' For Women With Previous Breast Cancer." ScienceDaily. www.sciencedaily.com/releases/2004/02/040203234441.htm (accessed March 3, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 3, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mom Triumphs Over Tragedy, Helps Other Families

Mom Triumphs Over Tragedy, Helps Other Families

AP (Mar. 3, 2015) After her son, Dax, died from a rare form of leukemia, Julie Locke decided to give back to the doctors at St. Jude Children&apos;s Research Hospital who tried to save his life. She raised $1.6M to help other patients and their families. (March 3) Video provided by AP
Powered by NewsLook.com
Looted and Leaking, South Sudan's Oil Wells Pose Health Risk

Looted and Leaking, South Sudan's Oil Wells Pose Health Risk

AFP (Mar. 3, 2015) Thick black puddles and a looted, leaking ruin are all that remain of the Thar Jath oil treatment facility, once a crucial part of South Sudan&apos;s mainstay industry. Duration: 01:13 Video provided by AFP
Powered by NewsLook.com
Woman Convicted of Poisoning Son

Woman Convicted of Poisoning Son

AP (Mar. 3, 2015) A woman who blogged for years about her son&apos;s constant health woes was convicted Monday of poisoning him to death by force-feeding heavy concentrations of sodium through his stomach tube. (March 3) Video provided by AP
Powered by NewsLook.com
Treadmill Test Can Predict Chance Of Death Within A Decade

Treadmill Test Can Predict Chance Of Death Within A Decade

Newsy (Mar. 2, 2015) Johns Hopkins researchers analyzed 58,000 heart stress tests to come up with a formula that predicts a person&apos;s chances of dying in the next decade. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins